HER2 drugs for Colorectal Cancer
3 tracked HER2 drugs in the Colorectal Cancer race. The class explanation lives on the HER2 page; the full indication pipeline across every mechanism is on the Colorectal Cancer page.
1 approved / phase 42 Phase 3
Head-to-head evidence: Trastuzumab brengitecan vs Tucatinib · Trastuzumab rezetecan vs Tucatinib